Bentham Science Logo

Current Signal Transduction Therapy

Volume 14, 2 Issues, 2019
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access

Contents

Current Signal Transduction Therapy, Volume 7 - Number 3




Bladder Cancer and Stem Cells

, 7(3): 209 - 219

Tomasz Drewa, Sandra Krzyzanowska, Andrzej Marszalek and Anna Bajek


DOI: 10.2174/157436212802481556


Myogenic Differentiation of Mesenchymal Stem Cells is Induced by Striated Muscle Influences in vitro

, 7(3): 220 - 227

Anna Bajek, Tomasz Drewa, Romana Joachimiak, Zaneta Spoz, Maciej Gagat, Magdalena Bodnar, Robert Debski, Alina Grzanka and Andrzej Marszalek


DOI: 10.2174/157436212802481510



YB-1 Protein and Multidrug Resistance of Tumor Cells

, 7(3): 237 - 246

Alla Stavrovskaya, Tatyana Stromskaya, Ekaterina Rybalkina, Natalia Moiseeva, Andrey Vaiman, Sergey Guryanov, Lev Ovchinnikov and Gelena Guens


DOI: 10.2174/157436212802481592




Tailored Angiogenesis Inhibition in Cancer Therapy: Respecting the Heart to Improve the Net Outcome

, 7(3): 265 - 288

Jasmine Passerini, Adriana Romiti, Chiara D'Antonio, Vittoria Mastromarino, Paolo Marchetti, Massimo Volpe and Elena Conti


DOI: 10.2174/157436212802481565







Editor-in-Chief

Jingxuan Yang
The University of Oklahoma Health Science Center
Oklahoma City, OK
USA

Biography View Full Editorial Board

Journal History

Current Signal Transduction Therapy was launched in 2006. Dr. Jingxuan Yang serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Related Journals

Related eBooks

eBooks Catalog